World Health Organization. (2019). International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: WHO Press.
[2]
Jameson, J.L., et al. (Eds.). (2018). Harrison's Principles of Internal Medicine, 20th Edition. New York: McGraw-Hill Education.
[3]
Daroff, R.B., et al. (Eds.). (2020). Bradley's Neurology in Clinical Practice, 7th Edition. Philadelphia: Elsevier.
[4]
Graus, F., et al. (2004). Recommended diagnostic criteria for paraneoplastic neurological syndromes. Journal of Neurology, Neurosurgery & Psychiatry, 75(8), 1135-1140.
[5]
Dalmau, J., & Rosenfeld, M.R. (2008). Paraneoplastic syndromes of the CNS. The Lancet Neurology, 7(4), 327-340.
[6]
Pelosi, E., et al. (2015). Paraneoplastic cerebellar degeneration: early detection but not cure. Journal of Neuro-Oncology, 125(2), 429-435.
[7]
Giometto, B., et al. (2012). Autoimmune encephalitis and anti-neural antibody search: a Pandora's box. Neurological Sciences, 33(2), 233-237.
[8]
Tüzün, E., & Dalmau, J. (2007). Limbic encephalitis and variants: classification, diagnosis and treatment. The Neurologist, 13(5), 261-271.